Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$1.61 - $2.54 $18,862 - $29,758
11,716 Added 56.52%
32,446 $58,000
Q2 2023

Jul 25, 2023

SELL
$1.14 - $1.95 $18,513 - $31,668
-16,240 Reduced 43.93%
20,730 $38,000
Q1 2023

Apr 24, 2023

BUY
$1.2 - $2.19 $44,364 - $80,964
36,970 New
36,970 $49,000
Q2 2022

Jul 27, 2022

BUY
$2.2 - $4.2 $63,879 - $121,951
29,036 New
29,036 $69,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Qcm Cayman, Ltd. Portfolio

Follow Qcm Cayman, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Qcm Cayman, Ltd. with notifications on news.